WebApr 12, 2010 · Column type Active phase Temperature (C) I Reference Comment; Capillary: OV-1: 190. 1690. Erdmann, Rochholz, et al., 1992: Large deviations from similar measurements Phosphoramide is a chemical compound with the molecular formula O=P(NH2)3. It is a derivative of phosphoric acid in which each of the hydroxyl groups have been replaced with an amino group. Phosphoramide arises from the reaction of phosphoryl chloride with ammonia. It is a white solid that is soluble in polar solvents. In moist air, it hydrolyzes to an ammonium salt:

I-Phosphamide - Antineoplastic Agents, Immunosuppressive …

Cyclophosphamide (CP), also known as cytophosphane among other names, is a medication used as chemotherapy and to suppress the immune system. As chemotherapy it is used to treat lymphoma, multiple myeloma, leukemia, ovarian cancer, breast cancer, small cell lung cancer, neuroblastoma, and … See more Cyclophosphamide is used to treat cancers and autoimmune diseases. It is used to quickly control the disease. Due to its toxicity, it is replaced as soon as possible by less toxic drugs. Regular and frequent laboratory … See more Like other alkylating agents, cyclophosphamide is teratogenic and contraindicated in pregnant women (pregnancy category D) except for life-threatening … See more Oral cyclophosphamide is rapidly absorbed and then converted by mixed-function oxidase enzymes (cytochrome P450 system) … See more As reported by O. M. Colvin in his study of the development of cyclophosphamide and its clinical applications, Phosphoramide mustard, one of the principal toxic … See more Adverse drug reactions from cyclophosphamide are related to the cumulative medication dose and include chemotherapy-induced nausea and vomiting See more The main effect of cyclophosphamide is due to its metabolite phosphoramide mustard. This metabolite is only formed in cells that have low levels of ALDH. Phosphoramide … See more The abbreviation CP is common, although abbreviating drug names is not best practice in medicine. See more WebAug 1, 2007 · Purpose: Alkylating agents and the anti-CD20 monoclonal antibody rituximab are among appropriate choices for the primary treatment of symptomatic patients with Waldenström macroglobulinemia (WM), and they induce at least a partial response in 30% to 50% of patients. To improve these results, we designed a phase II study that included … inattentive subtype

Cyclophosphamide - PubMed

WebJul 4, 2024 · Cyclophosphamide is a medication primarily used in the management and treatment of neoplasms, including multiple myeloma, sarcoma, and breast cancer. Cyclophosphamide is a nitrogen mustard that exerts its anti-neoplastic effects through alkylation. This activity reviews the indications, contraindica … WebOct 25, 2024 · phosphamide g 1.19–1.31 Conduc-tivity USP Cyclo-phospha-mide Re-lated Com-pound D RS 0.50 Cyclophosphamide related compound A h 1.40–1.70 Conduc-tivity USP Cyclo-phospha-mide Re-lated Com-pound A RS 2.0 Cyclophosphamide pyrophosphate analog i 1.46–1.67 Conduc-tivity USP Cyclo-phospha- WebPhosphamide hydrate C5H14NO4PS2 CID 121304179 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, … in aid of the emerald king 4